{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,25]],"date-time":"2026-02-25T06:58:09Z","timestamp":1772002689985,"version":"3.50.1"},"reference-count":21,"publisher":"Wiley","issue":"6","license":[{"start":{"date-parts":[[2010,4,27]],"date-time":"2010-04-27T00:00:00Z","timestamp":1272326400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Transfusion"],"published-print":{"date-parts":[[2010,6]]},"abstract":"<jats:p><jats:bold>BACKGROUND:<\/jats:bold> Little information exists on the specific transfusion\u2010related acute lung injury (TRALI) risk reduction practices used by multiple blood collecting institutions in the United States.<\/jats:p><jats:p><jats:bold>STUDY DESIGN AND METHODS:<\/jats:bold> An AABB\u2010appointed TRALI working group designed a set of questions about TRALI risk reduction for platelets (PLTs) and plasma. AABB member institutions were asked to respond via an Internet\u2010based survey during a 3\u2010week period in August through September 2009.<\/jats:p><jats:p><jats:bold>RESULTS:<\/jats:bold> Valid responses were received from 47 US blood centers (accounting for 1.57 million apheresis PLT units and 3.15 million whole blood\u2013derived transfusable plasma units) and 56 hospital blood collectors. Among the blood centers, 87 and 98% had initiated some PLT and plasma risk reduction, respectively. HLA antibody testing of plateletpheresis donors was performed by 20 (43%) blood centers. There was substantial variation in the number of pregnancies (from one to more than four) that triggered testing and most centers did not screen based on a transfusion history. Almost all centers had policies to redirect HLA antibody\u2013positive donors to whole blood donation and to potentially retest HLA antibody\u2013negative donors. There were no blood centers performing HNA antibody testing. Sex\u2010based risk reduction policies for plasma included all male, or predominantly male, and never\u2010pregnant females; these varied by blood center, blood group, and method of plasma collection. A majority of centers indicated increased production of plasma frozen within 24 hours after phlebotomy.<\/jats:p><jats:p><jats:bold>CONCLUSIONS:<\/jats:bold> Almost 3 years after the publication of the initial AABB bulletin on this issue, TRALI risk reduction strategies are commonly employed at most US blood centers. However, procedures are not uniform.<\/jats:p>","DOI":"10.1111\/j.1537-2995.2010.02659.x","type":"journal-article","created":{"date-parts":[[2010,4,28]],"date-time":"2010-04-28T20:02:53Z","timestamp":1272484973000},"page":"1312-1321","source":"Crossref","is-referenced-by-count":55,"title":["A national survey of transfusion\u2010related acute lung injury risk reduction policies for platelets and plasma in the United States"],"prefix":"10.1111","volume":"50","author":[{"given":"Steven","family":"Kleinman","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Brenda","family":"Grossman","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Patricia","family":"Kopko","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"311","published-online":{"date-parts":[[2010,6]]},"reference":[{"key":"e_1_2_8_2_2","unstructured":"Association Bulletin #06\u201007.Transfusion\u2010related acute lung injury. Issued November 3 2006. [cited 2010 Jan 10]. Available from: URL:http:\/\/www.aabb.org\/Content\/Members_Area\/Association_Bulletins\/ab06\u201007.htm"},{"key":"e_1_2_8_3_2","unstructured":"Association Bulletin #07\u201003.Clarifications to recommendations to reduce the risk of TRALI. Issued November 28 2007. [cited 2010 Jan 10]. Available from: URL:http:\/\/www.aabb.org\/Content\/Members_Area\/Association_Bulletins\/ab07\u201003.htm"},{"key":"e_1_2_8_4_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1423-0410.2006.00870.x"},{"key":"e_1_2_8_5_2","first-page":"161","volume-title":"TRALI: mechanisms, management, and prevention","author":"Kleinman S","year":"2008"},{"key":"e_1_2_8_6_2","unstructured":"WhitakerBI GreenJ KingMR LeibergLL MathewSM SchlumpKS SchreiberGB.The 2007 national blood collection and utilization survey.2006. [cited 2010 Jan 10]. Available from: URL:http:\/\/www.hhs.gov\/ophs\/bloodsafety\/2007nbcus_survey.pdf"},{"key":"e_1_2_8_7_2","unstructured":"WhitakerBI SullivanMS.The 2005 nationwide blood collection and utilization survey.2008. [cited 2010 Jan 10]. Available from: URL:http:\/\/www.hhs.gov\/bloodsafety\/2005NBCUS.pdf"},{"key":"e_1_2_8_8_2","volume-title":"Report on blood collection and transfusion in the United States in 2001","author":"National Blood Data Resource Center","year":"2003"},{"key":"e_1_2_8_9_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1537-2995.2009.02206.x"},{"key":"e_1_2_8_10_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1537-2995.2008.01684.x"},{"key":"e_1_2_8_11_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1537-2995.2008.01902.x"},{"key":"e_1_2_8_12_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1537-2995.2009.02556.x"},{"key":"e_1_2_8_13_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1423-0410.2008.01092.x"},{"key":"e_1_2_8_14_2","doi-asserted-by":"publisher","DOI":"10.1038\/nm.2070"},{"key":"e_1_2_8_15_2","first-page":"45A","article-title":"Effective reduction of TRALI risk with plasma collected predominantly from male donors [abstract]","volume":"49","author":"Eder AF","year":"2009","journal-title":"Transfusion"},{"key":"e_1_2_8_16_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.tmrv.2009.06.007"},{"key":"e_1_2_8_17_2","first-page":"13","volume-title":"TRALI: mechanisms, management, and prevention","author":"Khan H","year":"2008"},{"key":"e_1_2_8_18_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1537-2995.2007.01535.x"},{"key":"e_1_2_8_19_2","unstructured":"Food and Drug Administration.Fatalities Reported to FDA Following Blood Collection and Transfusion: Annual Summary for Fiscal Year 2008.2009. [cited 2010 Jan 10]. Available from: URL:http:\/\/www.fda.gov\/downloads\/BiologicsBloodVaccines\/SafetyAvailability\/BloodSafety\/UCM113904.pdf"},{"key":"e_1_2_8_20_2","unstructured":"Serious Hazards of Transfusion Steering Committe.Serious hazards of transfusion: annual report 2008 [monograph on the Internet]. Manchester (UK):SHOT Office;2009. [cited 2010 Jan 10]. Available from: URL:http:\/\/www.shotuk.org\/SHOT%20Report%202008.pdf"},{"key":"e_1_2_8_21_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1537-2995.2009.02340.x"},{"key":"e_1_2_8_22_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1537-2995.2009.02338.x"}],"container-title":["Transfusion"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fj.1537-2995.2010.02659.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/j.1537-2995.2010.02659.x","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,10,14]],"date-time":"2023-10-14T03:42:44Z","timestamp":1697254964000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/j.1537-2995.2010.02659.x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,6]]},"references-count":21,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2010,6]]}},"alternative-id":["10.1111\/j.1537-2995.2010.02659.x"],"URL":"https:\/\/doi.org\/10.1111\/j.1537-2995.2010.02659.x","archive":["Portico"],"relation":{},"ISSN":["0041-1132","1537-2995"],"issn-type":[{"value":"0041-1132","type":"print"},{"value":"1537-2995","type":"electronic"}],"subject":[],"published":{"date-parts":[[2010,6]]}}}